Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors.
about
Tumor derived mutations of protein tyrosine phosphatase receptor type k affect its function and alter sensitivity to chemotherapeutics in gliomaEpigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer.Regulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysisMutational analyses of WNT7A and HDAC11 as candidate tumour suppressor genes in sporadic malignant pancreatic endocrine tumoursSASH1 regulates proliferation, apoptosis, and invasion of osteosarcoma cell.Overexpression of SASH1 related to the decreased invasion ability of human glioma U251 cells.MicroRNA-205 promotes cell invasion by repressing TCF21 in human ovarian cancer.Insulin secretion and insulin-producing tumorsA major lung cancer susceptibility locus maps to chromosome 6q23-25.Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: The Papanicolaou Society of Cytopathology Guidelines.Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanomaKnockdown of protein tyrosine phosphatase receptor U inhibits growth and motility of gastric cancer cells.Endocrine tumors of the digestive tract and pancreas: histogenesis, diagnosis and molecular basis.Genetic alterations in combined neuroendocrine neoplasms of the lung.Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: the Papanicolaou Society of Cytopathology guidelines for pancreatobiliary cytologyGenome-wide appraisal of thyroid cancer progression.Molecular genetics of gastroenteropancreatic endocrine tumors.Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions.Surgical treatment of non-functioning pancreatic islet cell tumors.Historical, current and future perspectives on gastrointestinal and pancreatic endocrine tumors.The molecular genetics of gastroenteropancreatic neuroendocrine tumors.Molecular profiles of gastroenteropancreatic endocrine tumors.Molecular genetic events in gastrointestinal and pancreatic neuroendocrine tumors.Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.Pancreatic neuroendocrine tumors: a comprehensive review.MSH2 and CXCR4 involvement in malignant VIPoma.Deletion of chromosomal region 6q14-16 in prostate cancer.Thermodynamic stability, unfolding kinetics, and aggregation of the N-terminal actin-binding domains of utrophin and dystrophin.UTRN on chromosome 6q24 is mutated in multiple tumors.Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastases.Accumulation of beta-catenin protein, mutations in exon-3 of the beta-catenin gene and a loss of heterozygosity of 5q22 in solid pseudopapillary tumor of the pancreas.The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancersProfiling of GEPNETs
P2860
Q21559658-233A8973-09EB-436A-AEDE-B89C0EF79A56Q24538785-9D038BF1-DDE1-4BEE-9735-C670AABEDD7EQ26865296-D0211415-C98E-4723-A1C2-5F3B4C00F393Q28281731-9DC3121E-1B25-4DF8-AA50-02FE0411AA4AQ30009982-27E0A4CD-6B0F-4CE4-8F19-A6E8198BDA78Q30010026-20AF3753-BB66-4B40-B60A-783595E69FFBQ33644599-1E6ED7F2-8C0A-473B-A3BA-A0429B6D6141Q33786707-EBBD9081-CD44-43B4-AC22-5DC7EC44C20FQ33910059-20E40B74-5AB8-478E-B381-8493330BB705Q34127316-B4F795BD-A3A7-4741-8E38-3039565E04CBQ34201939-BC52DBD3-5C33-4D8E-A448-5318235B3ED7Q34371330-EEE7E6A8-62F0-4E69-B2BE-71F995D1187DQ34569319-DC9BBC24-B0A6-498C-BBEC-354AB2812A10Q34737984-6DAAE8D8-DE99-43EB-8577-659054C667A9Q35038199-7C330FB7-79E9-45B0-9A59-B18AC0651D23Q35747698-F897DB52-0A4D-4B20-918D-2AF1E0881D3AQ35778287-99B8F6C3-E5D9-4ECE-A2F4-C54ABFFAF8FAQ35929598-A5B0E27B-0277-490E-839E-36DE43B53463Q36047433-7DD3A5C1-2746-4982-BFF9-B2C7724B0636Q36284221-2A9C09AC-D352-4A8F-B327-09D5789D7161Q36301318-EAC2F517-69B5-4DB5-8DF4-CC65DF9D64EEQ36904566-14F499B7-B5A8-49E0-889D-60B7A9F4EE86Q37015839-EA91729C-AA4D-4163-B235-9A1AA27CA6FAQ37175960-A33D6CAB-1427-401A-AC13-092D6E727C20Q37995947-1BA1EAE9-61E2-4687-B2AB-B8A04EC802CFQ38066637-14D52EF3-EB7B-479E-A7A1-26163514A89FQ40696693-9CDD4848-0C12-4C9B-9D5E-DEE49C18B1D4Q41951688-1924DD2E-467E-45AB-B44B-232FDA7F7FECQ42829867-A06CAC8F-5CBF-4803-8BE0-B333B92DFA5FQ51548093-61A691ED-B8C0-4A57-B788-37142DB8D479Q53588957-8C56F1D3-9F05-483B-9192-BA633E374913Q56593831-8D14EC94-3C71-49CC-8476-49EE91FCA7CDQ58693024-59431797-3F6B-4A1A-84ED-3E8AA91B7CDC
P2860
Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Putative tumor suppressor loci ...... c endocrine pancreatic tumors.
@ast
Putative tumor suppressor loci ...... c endocrine pancreatic tumors.
@en
type
label
Putative tumor suppressor loci ...... c endocrine pancreatic tumors.
@ast
Putative tumor suppressor loci ...... c endocrine pancreatic tumors.
@en
prefLabel
Putative tumor suppressor loci ...... c endocrine pancreatic tumors.
@ast
Putative tumor suppressor loci ...... c endocrine pancreatic tumors.
@en
P2093
P2860
P1476
Putative tumor suppressor loci ...... c endocrine pancreatic tumors.
@en
P2093
A Barghorn
B Farspour
P Komminoth
P Saremaslani
P2860
P304
P356
10.1016/S0002-9440(10)64658-5
P407
P577
2001-06-01T00:00:00Z